Loading...
OTCM
APNHY
Market cap4.36bUSD
Aug 28, Last price  
8.80USD
Name

Aspen Pharmacare Holdings Ltd

Chart & performance

D1W1MN
OTCM:APNHY chart
P/E
P/S
1.46
EPS
Div yield, %
1.39%
Shrs. gr., 5y
-0.55%
Rev. gr., 5y
2.33%
Revenues
Net income
CFO
Dividend
Oct 03, 20250.12194 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Aspen Pharmacare Holdings Limited is a global pharmaceutical entity that develops, manufactures, and distributes a wide array of specialized and branded medicinal products. The company operates through two primary segments: Commercial Pharmaceuticals and Manufacturing. Its diverse product portfolio encompasses essential anesthetic agents, such as general anesthetics, muscle relaxants, and topical preparations. Aspen also provides a comprehensive suite of thrombosis treatments, including various injectable anticoagulants like low molecular weight heparins, Xa inhibitors, and other heparin derivatives. Beyond these, the firm markets numerous regional consumer, prescription, and over-the-counter brands, such as Circadin for sleep, Foxair for respiratory ailments, Maltofer as an iron supplement, Mybulen for pain management, and Zyloric for gout. Additionally, Aspen produces active pharmaceutical ingredients and finished dose form products for other companies. Established in 1850, the company's headquarters are located in Durban, South Africa.
IPO date
Dec 05, 1994
Employees
8,580
Domiciled in
ZA
Incorporated in
ZA

Valuation

No data to show